mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.008 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.7 |
0.01 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |